Skip to Main Content

Paper Details

Treatment-associated <i>TP53</i> DNA-binding domain missense mutations in the pathogenesis of secondary gliosarcoma.
Oncotarget
19
2017
CDH1, CDKN2A, EGFR, GBM, GBM spheres, Gliomaspheres, Gliosarcoma, JAK, PTEN, R110C, R175H, STAT, TMZ, TMZ-treated gliomaspheres, TP53, TP53 DBD, TP53 DNA-binding domain, cancer, cancer driver genes, glioblastoma, gliomasphere, gliomasphere cultures, gliomaspheres, gliosarcoma, microRNAs, secondary gliosarcoma, temozolomide, tumor, tumors
Author NameAffiliation
Eunjee LeeIcahn School of Medicine at Mount Sinai
Eunjee LeeIcahn School of Medicine at Mount Sinai
Robert SebraIcahn School of Medicine at Mount Sinai
Robert SebraIcahn School of Medicine at Mount Sinai
Jun ZhuIcahn School of Medicine at Mount Sinai
  • 1 - 5

Datasets

Release 1.2